The U.S. Army Medical Research and Materiel Command (USAMRMC) posted the
following three announcements in the CBD (Commerce Business Daily) on 9
May 1995:
Epidemiological Studies Persian Gulf War Illnesses (PGI-l)
Pyridostigmine Bromide studies Persian Gulf War Illnesses (PGI-2)
Clinical Research and Other Studies Persian Gulf War Illnesses (PGI-3)
No conventional solicitation will be issued by the Army for this action.
Updates will be posted to various newsgroups if/when they are received by
AIBS.
For updates on this and other biomedical RFPs, proposal solicitations,
fellowships, and research opportunities, check the AIBS Gopher at
gopher.aibs.org or via WWW at gopher://aibs.org - updates will appear in
the PROFESSIONAL OPPORTUNITIES folder.
NOTE: Direct all inquires to the US ARMY Point of Contact:
CRAIG D. LEBO, 301-619-2036
U.S. ARMY MED. RESEARCH ACQUISITION ACT
MCMR-RMA
FORT DETRICK BLDG, 820,
FREDERICK MD 21702-5014:
+++++++++++++++++++++++++++++++++++++++++++++++
RECORD NUMBER: 1342PRA0008
CBD ISSUE DATE: 5/9/95 SECTION: Procurements FSC CODE: A
TITLE: R&D STREAMLINED CONTRACT
SOL DAMD17-95-#-0008 DUE 052495
Point of Contact: CRAIG D. LEBO, 301-619-2036
Epidemiological Studies Persian Gulf War Illnesses (PGI-l)
The U.S. Army Medical Research and Materiel Command (USAMRMC) on behalf of
the Departments of Defense, Veteran's Affairs and Health and Human
Services Cooperative Research Program, is supporting Epidemiological
studies of possible health consequences of military service or employment
in the Southwest Asia theater of operations during the Persian Gulf
War. The USAMRMC is seeking proposals to study the incidence,
prevalence, and nature of illnesses and symptoms and risk factors
associated to symptoms or illnesses as a result of Persian Gulf War
Service. No conventional Solicitation will be issued for this action,
but the details of the requirements will appear in a future edition of the
Commerce Business Daily (CBD). This action follows the guidelines of the
RED streamlined contracting procedure outlined in DFARS 235.7000. Any
offeror desiring to receive any amendments to this solicitation and any
supplemental packages, if developed, should send their name and address,
citing this announcement to the issuing office.
U.S. ARMY MED.RESEARCH ACQUISITION ACT,
MCMR-RMA,
FORT DETRICK BLDG. 820,
FREDERICK MD 21702-5014 (0125)
+++++++++++++++++++++++++++++++++++++++++++++++
NUMBER: 1342PRA0003
CBD ISSUE DATE; 5/9/95 SECTION: Procurements FSC CODE!: A
TITLE: R&D STREAMLINED CONTRACT
SOL DAMDl7-95-#-0009 DUE 05/24/95 ,
POC CRAIG D. LEBO, 301-619-2036
Pyridostigmine Bromide studies Persian Gulf War Illnesses (PGI-2)
The U.S. Army Medical Research and Materiel. command (USAMRMC) on behalf
of the Departments of Defense, Veteran's Affairs and Health and Human
Services Cooperative Research Program, is supporting Pyridostigmine
studies of possible health consequences of military service or employment
in the Southwest Asia theater of operations during the Persian Gulf War.
The USAMRMC is seeking proposals to determine whether the use of
pyridostigmine bromide alone as a pretreatment against nerve agents, or
combined with exposures to pesticides, other organophosphorous compound,
caramates or other relevant chemicals would result in increased
toxicity. No conventional solicitation will be issued for this actions
but the details of the requirements will appear in a future edition of the
Commerce Business Daily (CBD). This action follows the guidelines of
the R&D streamlined contracting procedure outlined in DFARS 235.7000.
Any offeror desiring to receive any amendments to this solicitation and
any supplemental packages, if developed, should send their name and
address, citing this announcement to the issuing office.
U.S. ARMY MED. RESEARCH ACQUISITION ACT,
MCMR-RMA (PGI-2),
FORT DETRICK BLDG, 820,
FREDERICK MD 21702-5014
+++++++++++++++++++++++++++++++++++++++++++++++
RECORD NUMBER: 1342PRA0006
CBD ISSUE DATE: 5/9/95 SECTION: Procurements FSC CODE: A TITLE: R&D
STREAMLINED CONTRACT
SOL DAMDl7-95-#-0010 DUE 05/24/95
POC CRAIG D. LEBO, 301-619-2036
Clinical Research and Other Studies Persian Gulf War Illnesses (PGI-3)
The U.S. Army Medical Research and Materiel Command (USAMRMC) on behalf of
the Departments, of Defense, Veteran's Affairs and Health and Human
Services Cooperative Research Program, is supporting Clinical Research and
other studies on the health consequences of military service or employment
in the Southwest Asia theater of operations during the Persian Gulf War.
The USAMRMC is seeking proposals for clinical studies and other research
on the cause(s), mode(s), of transmission(s), and appropriate treatment(
s) of Persian Gulf War illnesses.. No conventional solicitation will be
is sued for this action, but the details of the requirements will appear
in a future edition of the Commerce Business Daily (CBD). This action
follows the guidelines of the R&D streamlined Contracting procedure
outlined in DFARS 235.7000. Any offeror desiring to receive any
amendments to this solicitation and any supplemental packages, if
developer should send their name and address Citing this announcement to
the issuing office.
U.S. ARMY MED. RESEARCH ACQUISITION ACT,
MCMR-RMA (PGI- 3)
FORT DETRICK BLDG, 820
FREDERICK MD 21702-5014
--
Keith L. Cowing - Manager of Planning and Operations
American Institute of Biological Sciences
10700 Parkridge Blvd Suite 380 - Reston, VA, USA 22091
703-758-1212 voice - 703-758-1222 fax
kcowing at aibs.org - gopher://aibs.org
